Summit Moving Lead Drugs with Wellcome Trust Award
LONDON – Summit plc is making headway with its two lead programs, winning a £4 million (US$6.42 million) translation award from the Wellcome Trust for clinical trials of SMT19969, a narrow-spectrum antibiotic for treating Clostridium difficile infections.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter